Cargando…

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons. The mechanisms leading to motor neuron degeneration in ALS are unclear. However, there is evidence for involvement of endoplasmic reticulum (ER) stress and the unfolded protein resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vieira, Fernando G., Ping, Qinggong, Moreno, Andy J., Kidd, Joshua D., Thompson, Kenneth, Jiang, Bingbing, Lincecum, John M., Wang, Monica Z., De Zutter, Gerard S., Tassinari, Valerie R., Levine, Beth, Hatzipetros, Theo, Gill, Alan, Perrin, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545826/ https://www.ncbi.nlm.nih.gov/pubmed/26288094 http://dx.doi.org/10.1371/journal.pone.0135570

Ejemplares similares

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
por: Vieira, Fernando G., et al.
Publicado: (2017)

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
por: Gill, Cindy, et al.
Publicado: (2019)

Guanabenz modulates microglia and macrophages during demyelination
por: Thompson, Kaitlyn Koenig, et al.
Publicado: (2020)

The ALS-inducing factors, TDP43(A315T) and SOD1(G93A), directly affect and sensitize sensory neurons to stress
por: Vaughan, Sydney K., et al.
Publicado: (2018)

Guanabenz—an old drug with a potential to decrease obesity
por: Kotańska, Magdalena, et al.
Publicado: (2022)

Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling
por: Takigawa, Shinya, et al.
Publicado: (2016)

Effect of Guanabenz on Rat AMD Models and Rabbit Choroidal Blood Flow
por: Shen, Yi, et al.
Publicado: (2011)

Guanabenz Interferes with ER Stress and Exerts Protective Effects in Cardiac Myocytes
por: Neuber, Christiane, et al.
Publicado: (2014)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration
por: Vieira, Fernando G., et al.
Publicado: (2014)

Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian Prions
por: Tribouillard-Tanvier, Déborah, et al.
Publicado: (2008)

Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
por: Osborn, Maire F., et al.
Publicado: (2015)

Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1
por: Witkamp, Diede, et al.
Publicado: (2022)

The Antihypertensive Guanabenz Exacerbates Integrated Stress Response and Disrupts the Brain Circadian Clock
por: Lin, Hao, et al.
Publicado: (2023)

SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants
por: Niikura, Takako, et al.
Publicado: (2014)

Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity
por: Yoshino, Satoshi, et al.
Publicado: (2020)

Guanabenz Acetate Induces Endoplasmic Reticulum Stress–Related Cell Death in Hepatocellular Carcinoma Cells
por: Kang, Hyo Jeong, et al.
Publicado: (2019)

Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation
por: Martynowicz, Jennifer, et al.
Publicado: (2019)

Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy
por: Barbezier, Nicolas, et al.
Publicado: (2011)

In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3
por: Callejo, Gerard, et al.
Publicado: (2020)

Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice
por: Iyer, Abhirami K., et al.
Publicado: (2023)

PPP1R15A-mediated dephosphorylation of eIF2α is unaffected by Sephin1 or Guanabenz
por: Crespillo-Casado, Ana, et al.
Publicado: (2017)

No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS
por: Gill, Alan, et al.
Publicado: (2009)

An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
por: Prudencio, Mercedes, et al.
Publicado: (2010)

Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons
por: Kumar, Meenakshi Sundaram, et al.
Publicado: (2022)

Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
por: Bella, Eleonora Dalla, et al.
Publicado: (2017)

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
por: Joyce, Peter I., et al.
Publicado: (2015)

The structure–function relationships and physiological roles of MnSOD mutants
por: Bonetta Valentino, Rosalin
Publicado: (2022)

Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α(2)-adrenoceptor and trace amine-associated receptor 1 ligand
por: Kotańska, Magdalena, et al.
Publicado: (2023)

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

Huntingtin Fragments and SOD1 Mutants Form Soluble Oligomers in the Cell
por: Park, Yang-Nim, et al.
Publicado: (2012)

Daf-2 Signaling Modifies Mutant SOD1 Toxicity in C. elegans
por: Boccitto, Marco, et al.
Publicado: (2012)

Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
por: Vehviläinen, Piia, et al.
Publicado: (2014)

Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
por: Palomo, Gloria M, et al.
Publicado: (2018)

Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants
por: Huai, Jisen, et al.
Publicado: (2019)

Hereditary motor and sensory neuropathy with SOD1-mutant: A case report
por: Luo, Zhong, et al.
Publicado: (2022)

Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice
por: Lee, Do-Yeon, et al.
Publicado: (2015)

Sod2 haploinsufficiency does not accelerate aging of telomere dysfunctional mice
por: Guachalla, Luis Miguel, et al.
Publicado: (2009)

Superoxide Dismutases (SODs) and SOD Mimetics
por: Borgstahl, Gloria E. O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gguoa6ujgp28at7ia4b3jjhfk7